Search Login Register

4-Aminopyridine (4 Aminopyridine) Summary

Description: One of the POTASSIUM CHANNEL BLOCKERS, with secondary effect on calcium currents, which is used mainly as a research tool and to characterize channel subtypes.

Also Known As: 4 Aminopyridine; 4-Aminopyridine Sustained Release; Fampridine-SR; Pymadine; VMI-103 Show All >>

Networked: 495 relevant articles (36 outcomes, 67 trials/studies) for this Bio-Agent

Key Diseases for which 4-Aminopyridine is Relevant

  1. Multiple Sclerosis : 11 outcomes 17 studies in 57 results
  2. Seizures (Seizure) : 10 outcomes 10 studies in 159 results
  3. Spinal Cord Injuries (Spinal Cord Injury) : 6 outcomes 17 studies in 43 results
  4. Alzheimer Disease (Alzheimer's Disease) : 2 outcomes 2 studies in 7 results
  5. Pathologic Nystagmus : 2 outcomes 1 study in 2 results
Show All >>

Drugs Related to 4-Aminopyridine

  1. N-Methylaspartate (NMDA)
  2. Kainic Acid (Kainate)
  3. Potassium Channels (Potassium Channel)
  4. Pentylenetetrazole (Metrazol)
  5. gabapentin (Neurontin)
  6. alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)
  7. Episodic ataxia with nystagmus
  8. Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)
  9. Verapamil (Calan)
  10. Pilocarpine (Ocusert)
Show All >>

Therapies Related to 4-Aminopyridine

  1. Intravenous Infusions
  2. Off-Label Use
  3. Optical Devices
  4. Contact Lenses
  5. Oral Administration
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.